Antibacterial Advantage Onkos Surgical is advancing antibacterial implant technology with NanoCept, including the ELEOS Total Femoral Adapter, and is actively expanding production through the NanoCept Innovation Center in New Jersey, signaling a growth-ready opportunity for hospitals seeking infection-reducing implants.

Precision Orthopaedics The company emphasizes precision orthopaedics through virtual surgical planning, 3D modeling and printing, and tailored implant design, offering a compelling value proposition for health systems pursuing personalized reconstruction and reduced revision rates.

Strategic Financing With a venture loan facility of 35 million secured to accelerate commercialization, there is demonstrated capital support and liquidity to scale partnerships, pilot programs, and large-scale deployments with academic medical centers.

Academic Adoption Over 350 leading US academic medical institutions rely on Onkos Precision Orthopaedics, indicating strong credibility and a ready pipeline for expansion via research collaborations, sponsored trials, and training programs.

Expansion Momentum Recent market releases and facility openings in New Jersey, alongside FDA clearance activity, point to a timeline of near-term product launches and regional expansion opportunities to engage hospitals and trauma centers seeking advanced orthopaedic solutions.